PpProf. Peptide
Back to Peptide Library

GHK-Cu

Skin Health & Anti-AgingResearch-Grade

Last reviewed: May 24, 2026

Also Known As: Copper Tripeptide-1, Glycyl-L-Histidyl-L-Lysine Copper, GHK Copper Peptide

Peptide Class: Natural Copper-Binding Tripeptide — Multi-Pathway Gene Expression Modulator

Regulatory Status: Topical permitted in cosmetics. Injectable not FDA-approved — commercial compounding prohibited (2023). Not on WADA prohibited list.

What is GHK-Cu?

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) first isolated by Loren Pickart in 1973 from human plasma albumin. It exists naturally in plasma, saliva, and urine — at age 20 plasma levels average ~200 ng/mL, declining to ~80 ng/mL by age 60. This decline coincides with reduced regenerative capacity. GHK-Cu has one of the broadest mechanistic profiles of any peptide on Prof. Peptide — gene expression studies show it modulates over 4,000 human genes related to collagen synthesis, wound healing, anti-inflammatory signaling, and tissue remodeling. Often paired with BPC-157 + TB-500 in the GLOW blend for skin and recovery, or in the broader KLOW blend. New to peptide research? Start with the basics →

Reported benefits:

  • Stimulates collagen and glycosaminoglycan synthesis in skin fibroblasts
  • Modulates expression of 4,000+ human genes related to tissue repair
  • Accelerates wound healing (40–50% faster wound closure in animal models)
  • Supports hair follicle stimulation comparable to Minoxidil 5% in some studies
  • Anti-inflammatory and antioxidant activity
  • Available topically (cosmetic skincare) and as injectable research peptide

Common research dose: Topical: 1–3% concentration in serums/creams, applied 1–2× daily. Injectable research protocol: 1–2 mg subcutaneously, 30-day cycle (typically 1 mg days 1–15, escalating to 2 mg days 16–30), then 30-day break.

Where to buy: PP maintains a vetted list of peptide vendors with verified discount codes. See Verified Discount Codes → for current options.

How does GHK-Cu work?

GHK-Cu shuttles copper into cells where it powers enzymes including lysyl oxidase (collagen crosslinking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (cellular energy). It modulates expression of 4,000+ human genes related to collagen synthesis, tissue remodeling, and anti-inflammatory signaling — the breadth of this gene effect is unusual for any peptide. The combined copper-shuttle + gene-expression mechanism is what gives GHK-Cu its broad regenerative profile.

  1. Copper Shuttle [1]. GHK-Cu carries copper into cells where it powers enzymes including lysyl oxidase (collagen crosslinking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (cellular energy). The copper-binding capability is what gives GHK-Cu its name and broad mechanistic reach.
  2. Gene Expression Modulation [2]. Modulates expression of 4,000+ human genes. Upregulates Type I and III collagen, decorin (302% increase), and glycosaminoglycans. Downregulates inflammatory and senescence pathways. This breadth of gene effect is unusual for any peptide.
  3. Collagen Synthesis [3]. Stimulates collagen synthesis at picomolar to nanomolar concentrations in skin fibroblasts. Notably stimulates BOTH collagen production AND breakdown of damaged collagen via matrix metalloproteinases — true tissue remodeling, not just deposition.
  4. Hair Follicle Stimulation [4]. Activates Wnt signaling in dermal papilla cells (anagen growth phase). Stimulates fibroblasts and angiogenesis around follicles. Inhibits TGF-beta-induced follicle miniaturization. This mechanism is distinct from Minoxidil's vasodilation pathway.
  5. Anti-Inflammatory & Antioxidant [5]. Reduces TNF-alpha and IL-6 in dermal fibroblasts. Stimulates antioxidant enzymes including superoxide dismutase. Reduces oxidative stress markers in cellular and animal studies.

What is GHK-Cu used for?

GHK-Cu's research evidence base is one of the broadest of any peptide — decades of cell, animal, and human studies across wound healing, skin rejuvenation, hair growth, anti-aging gene expression, and systemic healing applications. The Pickart-Margolina gene expression work demonstrating 'resetting DNA to a healthier state' via 4,000+ gene modulation is what distinguishes GHK-Cu from single-pathway compounds.

  1. Wound Healing [6]. Animal studies show 40–50% faster wound closure. In rat ischemic skin flap models, GHK-Cu reduced wound size 64.5% vs 28.2% control over 13 days. Effects observed in dermal, corneal, and surgical wound models.
  2. Skin Rejuvenation [7]. Pilot studies on aged skin show increased thickness, elasticity, hydration, and collagen density. Comparable to tretinoin in some endpoints, with cleaner tolerability profile.
  3. Hair Growth. Studies suggest performance comparable to Minoxidil 5% via different mechanism (Wnt activation vs vasodilation). Topical formulations widely marketed for hair regrowth applications.
  4. Anti-Aging Gene Expression [2]. Pickart and Margolina's gene expression work demonstrates "resetting DNA to a healthier state" via 4,000+ gene modulation. The breadth of effect is what distinguishes GHK-Cu from single-pathway compounds.
  5. Systemic Healing. Animal studies show systemic effect: GHK-Cu injected in one tissue area improves healing at distant sites (rats, mice, pigs). This systemic activity is part of the rationale for injectable use over topical-only application.

How long does GHK-Cu take to work?

GHK-Cu effects develop on multiple timescales depending on route. Topical: visible skin texture changes typically 4–8 weeks of consistent use. Injectable: skin improvements within the first 30-day cycle; hair changes typically 60–90 days (second cycle). Systemic effects (gene expression modulation) are measurable within hours of dosing but cumulative over cycles. Most users complete 3 injectable cycles before assessing full results.

Topical: visible skin texture changes typically 4–8 weeks of consistent use. Injectable: skin improvements within the first 30-day cycle; hair changes typically 60–90 days (second cycle). Systemic effects (gene expression modulation) are measurable within hours of dosing but cumulative over cycles. Most users complete 3 injectable cycles before assessing full results — consistent with the gene-expression-driven mechanism where effects accumulate via tissue remodeling rather than acute pharmacology.

How is GHK-Cu dosed?

GHK-Cu is used both topically (cosmetic skincare — strongest evidence base, FDA-permitted) and as an injectable research peptide (FDA-restricted as of 2023). Topical dose is 1–3% in serums/creams applied 1–2× daily. Injectable research protocol is typically a 30-day phased cycle: 1 mg/day for days 1–15, then 2 mg/day for days 16–30, followed by a 30-day break.

  1. Topical (cosmetic). 1–3% concentration in serums or creams. Apply 1–2× daily after cleansing.
  2. Injectable Phase 1 (Days 1–15). 1 mg/day subcutaneously before bed.
  3. Injectable Phase 2 (Days 16–30). 2 mg/day subcutaneously.
  4. Cycle structure. 30 days on, 30 days off. Most users complete 3 cycles before assessing results.
  5. Reconstitution. 50 mg vial + 10 mL bacteriostatic water = 5 mg/mL (20 units = 1 mg). See How is GHK-Cu administered? for the full reconstitution table.

For most users, topical is the safer and more defensible starting point. Injectable adds systemic effects but carries the FDA restriction (compounded injectable preparation prohibited as of 2023) and quality-control concerns for research-grade material.

Need to calculate your dose? Convert mg to syringe units and plan reconstitution with the dosage calculator →.

How is GHK-Cu administered?

GHK-Cu is administered topically (cosmetic skincare — FDA-permitted) or by subcutaneous injection (FDA-restricted as of 2023). Topical use is the more defensible starting point and has the strongest evidence base. Injectable produces systemic effects across tissues but requires research-grade material and carries regulatory restrictions. For the practical mechanics of insulin syringes for the injectable route, see the syringes and injection technique guide.

  1. Topical. Apply to clean dry skin, twice daily. Avoid combining with raw vitamin C in the same product (copper-vitamin C interactions destabilize both ingredients).
  2. Injectable route. Subcutaneous injection at bedtime, at least 2 hours after last meal. Common sites: abdomen, thigh, upper arm.
  3. Time of day. Bedtime preferred (aligns with natural overnight tissue-repair pulses).
  4. With or without food. Empty stomach preferred for injectable (2+ hours after eating).
  5. Site rotation. Alternate abdomen, thigh, upper arm for injectable.
  6. Reconstitution handling. Bacteriostatic water, swirl gently, never shake. Light-sensitive — store in opaque container.
  7. Avoid direct sunlight. Avoid direct sunlight on injection sites for 24–48 hours post-injection.

Timing context. GHK-Cu's effects accumulate via gene expression and tissue remodeling rather than acute pharmacology — the per-dose plasma profile matters less than cycle consistency. Topical and injectable produce different effect profiles: topical drives localized skin effects through direct dermal exposure; injectable produces systemic gene-expression modulation across tissues. Many users combine both routes (topical for skin, injectable for systemic) during research cycles.

AspectRecommendation
FrequencyTopical: 1–2× daily. Injectable: once daily during 30-day cycle (3 cycles typical).
Best time of dayTopical: AM or PM. Injectable: bedtime preferred.
FoodInjectable: empty stomach preferred (2+ hours after eating)
Route choiceTopical for skin-focused (safer, FDA-permitted); injectable for systemic effects (FDA-restricted)
Half-lifeShort plasma half-life; biological effects persist via gene-expression changes
Steady-stateTissue effects accumulate over cycles — 3-cycle pattern is standard before full assessment

Reconstitution math. Choose your bacteriostatic water volume based on dose precision. Lower water volume = higher concentration = smaller syringe draw. GHK-Cu research vials are typically 50 mg — significantly larger than other research peptides. Because the per-dose amount is small (1–3 mg), higher reconstitution volumes (5–10 mL) are used to keep syringe draws practical. All units below are measured on a U-100 insulin syringe (100 units = 1 mL). The table assumes a 50 mg vial.

BAC waterConcentration1 mg dose2 mg dose3 mg dose5 mg dose
2 mL25 mg/mL4 units8 units12 units20 units
5 mL10 mg/mL10 units20 units30 units50 units
10 mL5 mg/mL20 units40 units60 units100 units

Units vs mcg. At a 50 mg vial, each unit drawn delivers 250 mcg of GHK-Cu at 2 mL reconstitution, 100 mcg at 5 mL, and 50 mcg at 10 mL — the reconstitution volume determines the mcg-per-unit conversion. For a primer on reading insulin syringes and choosing the right barrel size, see our guide on syringes and injection technique.

What does GHK-Cu stack well with?

GHK-Cu's canonical pairing is with BPC-157 + TB-500 in the GLOW blend for skin/recovery synergy, or in the KLOW blend (adds KPV). Topical retinoids combine well (collagen synthesis + cell turnover), and topical niacinamide is compatible. The most important non-stacking is vitamin C: topical high-concentration vitamin C destabilizes the copper complex, so apply at different times of day.

  1. BPC-157 + TB-500 (GLOW Stack). BPC-157 + TB-500 combined with GHK-Cu in the GLOW blend for skin/recovery synergy. KPV adds anti-inflammatory effect for the broader KLOW blend.
  2. Topical retinoids. Combination of GHK-Cu (collagen synthesis) + retinoid (cell turnover) is well-tolerated and synergistic.
  3. Vitamin C serum. Apply at separate times (AM vitamin C, PM GHK-Cu) to avoid copper-vitamin C neutralization.
  4. Topical niacinamide. Compatible — both support barrier function.
  5. Avoid: high-dose oral copper supplements. During injectable GHK-Cu cycles — theoretical risk of total copper overload.

What are the side effects of GHK-Cu?

GHK-Cu is NOT FDA-approved for injectable use (FDA prohibits compounded injectable commercial preparation as of 2023). Topical GHK-Cu is widely available in cosmetic formulations with decades of safe-use history. The most common practical issue is topical irritation — typically resolves with reduced concentration or frequency. Mild injection-site reactions are reported for injectable use. Copper allergy is a real but uncommon contraindication.

Common (most users)

  1. Mild injection site reactions. Injectable route only.
  2. Possible scalp or skin irritation. Topical route.
  3. “Copper uglies”. Transient skin purging in first 1–2 weeks (rare); self-resolving.

Less common (moderate)

  1. Mild headache. Uncommon.
  2. Mild fatigue. Uncommon.
  3. Allergic reactions. In copper-sensitive individuals.

Serious (rare)

  1. Copper allergy reactions. Hives, swelling, breathing issues — discontinue immediately.
  2. Theoretical copper toxicity. Negligible at standard doses but possible with chronic high-dose use.
  3. Long-term injectable safety. Not formally established.

GHK-Cu is NOT FDA-approved for injectable use. The FDA prohibits injectable GHK-Cu in commercial compounding as of 2023. Topical GHK-Cu is widely available in cosmetic formulations and has decades of safe-use history. The most common practical issue is topical irritation — typically resolves with reduced concentration or frequency.

Does GHK-Cu interact with other drugs?

GHK-Cu's most relevant interactions are with vitamin C (high-concentration topical destabilizes the copper complex — apply at different times), topical hydroquinone (limited data on combination), and copper-binding drugs like D-penicillamine or chelation therapy (theoretical interaction with injectable use). No significant systemic drug interactions documented at standard cosmetic doses.

  1. Vitamin C (high concentration topical). Destabilizes copper complex; apply at different times.
  2. Topical hydroquinone. Limited data on combination.
  3. No significant systemic drug interactions documented at standard cosmetic doses.
  4. Injectable: theoretical interaction with chelation therapy or D-penicillamine (copper-binding drugs).

How should GHK-Cu be stored?

  1. Lyophilized: -20°C long-term, 2–8°C short-term.
  2. Topical formulations: room temperature in opaque packaging (light-sensitive).
  3. Reconstituted injectable: 2–8°C, 30 days max.
  4. Avoid contact with pure vitamin C in formulations.
  5. Reconstitute with bacteriostatic water for injection. Swirl gently — do not shake.
  6. Discard if cloudy, discolored, or contains particles.

What are the limitations of GHK-Cu research?

GHK-Cu has one of the strongest evidence bases of any peptide on Prof. Peptide — decades of cell, animal, and human studies with consistent results across research groups. Topical use is established in cosmetic formulations and widely available without prescription. Injectable use is NOT FDA-approved and the FDA prohibits compounded injectable commercial preparation as of 2023. Long-term injectable safety data is not established. NOT currently on the WADA prohibited list.

GHK-Cu has one of the strongest evidence bases of any peptide on Prof. Peptide — decades of cell, animal, and human studies, with consistent results across research groups.

Topical GHK-Cu is established in cosmetic formulations and widely available without prescription. Injectable GHK-Cu is NOT FDA-approved. The FDA prohibits compounded injectable GHK-Cu commercial preparation as of 2023.

Most clinical evidence is for topical applications; systemic effects from injection are derived from animal studies and limited human research. Long-term injectable safety data is not established.

Anti-doping: GHK-Cu is NOT currently on the WADA prohibited list. Research-grade material is sold for laboratory use only.

Where to source GHK-Cu

Topical GHK-Cu is widely available in cosmetic skincare products at 1–3% concentrations. Injectable research-grade GHK-Cu is sold by specialty peptide vendors (note FDA restriction on compounded injectable as of 2023). The vendors highlighted below have been vetted for transparent third-party testing, traceable batch documentation, and verified discount codes — including a UK/EU shipping option for international research.

Peptide Partners10% off
Editor's Pick

Editor's Pick — 4-test purity program

Click to copy code

Shop Peptide Partners →
Particle Peptides10% off

UK/EU shipping

Click to copy code

Shop Particle Peptides →
Ascension Peptides50% off
Best Deal

Click to copy code

Shop Ascension Peptides →

See all 17 verified vendors →

GHK-Cu FAQ

Is GHK-Cu FDA-approved?

Topical GHK-Cu is widely available in cosmetic formulations without prescription. Injectable GHK-Cu is NOT FDA-approved — and the FDA prohibited compounded injectable GHK-Cu commercial preparation as of 2023. Most clinical evidence supports topical use; systemic effects from injection are derived from animal studies and limited human research.

How is GHK-Cu different from BPC-157?

Different mechanisms. GHK-Cu is a copper-binding tripeptide that modulates 4,000+ human genes related to collagen synthesis, tissue remodeling, and anti-inflammatory signaling — primarily through copper-shuttling and Wnt activation. BPC-157 is a 15-amino-acid peptide that drives angiogenesis (VEGF/eNOS) and tissue repair through nitric oxide and FAK-paxillin pathways. They are commonly stacked together (often in the GLOW blend) because their mechanisms are complementary, not redundant. See the BPC-157 vs GHK-Cu comparison for a side-by-side breakdown.

Topical vs injectable — which is better?

Topical has the strongest evidence base, the longest history of safe use, and is FDA-permitted in cosmetic formulations. Injectable produces systemic effects (gene expression modulation across tissues) but is not FDA-approved and has stricter regulatory restrictions. For skin-focused applications, topical is the more defensible choice. For broader regenerative effects (hair + skin + tissue), injectable is what's used in functional medicine settings — at the user's risk regarding regulatory and quality issues.

Does GHK-Cu work for hair loss?

Some studies suggest performance comparable to Minoxidil 5% via different mechanisms — GHK-Cu activates Wnt signaling in dermal papilla cells (anagen growth phase) and stimulates angiogenesis around follicles, while Minoxidil works via vasodilation. Hair changes typically take 60–90 days to become visible (often the second injectable cycle). Topical GHK-Cu products marketed for hair are widely available.

What are "copper uglies"?

Slang for transient skin purging — increased breakouts or skin reactivity in the first 1–2 weeks of GHK-Cu use as the peptide accelerates skin cell turnover. Uncommon and self-resolving. If skin irritation persists beyond 2 weeks, discontinue and assess for copper sensitivity.

Can I combine GHK-Cu with retinoids or vitamin C?

Retinoids — yes, generally well-tolerated. The combination of GHK-Cu (collagen synthesis) + retinoid (cell turnover) is a common synergistic skincare protocol. Vitamin C — apply at separate times (AM vitamin C, PM GHK-Cu). High-concentration topical vitamin C destabilizes the copper complex; both ingredients lose efficacy when applied simultaneously.

How long until I see results?

Topical: visible skin texture changes typically 4–8 weeks. Injectable: skin improvements within first 30-day cycle. Hair changes typically 60–90 days (second cycle). Systemic gene expression effects are measurable within hours of dosing but cumulative over cycles.

Where can I buy GHK-Cu?

Topical GHK-Cu is widely available in cosmetic skincare products at 1–3% concentrations. Injectable research-grade GHK-Cu is sold by specialty peptide vendors (note FDA restriction on compounded injectable as of 2023). PP maintains a list of vetted vendors with verified discount codes — see Verified Discount Codes →.

References

  1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
  2. Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: Resetting the Human Genome to Health. Biomed Res Int. 2014;2014:151479.
  3. Pickart L, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/
  4. Maquart FX, Pickart L, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988.
  5. Wikipedia. Copper peptide GHK-Cu. https://en.wikipedia.org/wiki/Copper_peptide_GHK-Cu
  6. Innerbody Research. GHK-Cu Peptide. https://www.innerbody.com/ghk-cu-peptide
  7. Pickart L. The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging. Oxid Med Cell Longev. 2012.

Published Studies

Plain-English summaries of the peer-reviewed studies behind the claims above. Click any title to read the source paper.

BioMed Research International / PMC · 2015Open Access
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration →

Pickart L, Vasquez-Soltero JM, Margolina A

The comprehensive review that established GHK-Cu as a multi-pathway skin regeneration agent. The paper documents that GHK-Cu — first isolated by Pickart in 1973 when he discovered it made aged liver tissue behave like younger tissue — accelerates wound healing, improves transplanted skin take, stimulates collagen and glycosaminoglycan synthesis, attracts immune and endothelial cells to injury sites, and restores replicative vitality to fibroblasts after radiation therapy. Crucially, plasma GHK levels decline from 200 ng/mL at age 20 to 80 ng/mL by age 60.

International Journal of Molecular Sciences / PMC · 2018Open Access
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data →

Pickart L, Margolina A

A landmark review synthesizing GHK-Cu's known biological actions with groundbreaking gene expression data from the Broad Institute's Connectivity Map. Using this publicly available genomic database, researchers found that GHK-Cu modulates expression of genes across an extraordinary range of categories — wound healing, collagen synthesis, anti-inflammatory signaling, nerve growth, antioxidant defense, and DNA repair.

Cosmetics (MDPI) · 2018Open Access
Skin Regenerative and Anti-Cancer Actions of Copper Peptides →

Pickart L, Margolina A

A focused review of GHK-Cu's applications in skin protection and cancer prevention — two applications that emerge from the same underlying mechanism of DNA repair and gene expression modulation. The paper documents how GHK-Cu's ability to modulate 84 genes associated with DNA repair and cancer suppression could make it relevant for skin cancer prevention alongside its established role in skin regeneration and anti-aging.

International Journal of Medical Sciences · 2025Open Access
Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration — A Comprehensive Review →

Medsci Research Group

The most current systematic review of GHK-Cu in wound healing, covering studies published between 2016 and 2025. The paper documents GHK-Cu's role across all phases of wound repair — stimulating fibroblast migration, enhancing collagen deposition, supporting angiogenesis, and facilitating extracellular matrix remodeling. It also covers advanced formulations including nanoparticle conjugates and hydrogels.

Archives of Facial Plastic Surgery / Liebertpub · 2006Paywalled
Effects of Topical Copper Tripeptide Complex on CO2 Laser-Resurfaced Skin →

Leyden JJ, et al.

One of the few controlled human clinical trials of GHK-Cu — examining its use after CO2 laser skin resurfacing in 13 patients. Patient satisfaction was significantly higher in the GHK-Cu group (p=.04), and data suggested superior improvement in wrinkle scores in Fitzpatrick classes II and III.

Skin Health & Anti-AgingCopper PeptideWound HealingResearch-Grade

Related Peptides

BPC-157TB-500KPVThymosin Alpha-1

Related Blends

GLOWKLOWWolverine Stack

Comparisons

BPC-157 vs GHK-Cu →

Need to calculate a dose?

Use the Prof. Peptide dosage calculator for accurate reconstitution and dosing math.

Open Calculator

We may earn commissions from peptide vendor affiliate links.

Have a question about GHK-Cu? Send us an email →

For educational and research purposes only. Not medical advice. Not for human use.